Tiziana Life Sciences PLC ( Tiziana or the Company ) Directorate Change London / New York, 18 June 2020 - Tiziana Life Sciences plc (NASDAQ: TLSA / AIM: TILS), the U.S. and U.K. biotechnology company that focuses on the

Tiziana Life Sciences PLC

("Tiziana" or the "Company")

London / New York, 18 June 2020 - Tiziana

Life Sciences plc (NASDAQ: TLSA / AIM: TILS), the U.S. and U.K. biotechnology company that focuses on the discovery and development

of novel molecules to treat human disease in oncology and immunology, announces Gregor MacRae is standing down as a director of

the Company with immediate effect.

Gabriele Cerrone, Chairman of Tiziana, said

"I thank Gregor for his contribution to the Board and the Company and wish him well in his other interests. We are currently

in the process of recruiting a new, seasoned non-executive director with extensive NASDAQ audit committee experience and hope to

make a formal announcement shortly".

This announcement contains inside information

for the purposes of Article 7 of EU Regulation 596/2014.

For further enquiries:

For more information go to http://www.tizianalifesciences.com